<DOC>
	<DOCNO>NCT00752778</DOCNO>
	<brief_summary>To evaluate diagnosis value MRI positon emission tomography ( PET ) scan study macrophagic infiltration brain modification multiple sclerosis ( MS ) patient treat Natalizumab ( Tysabri ) .</brief_summary>
	<brief_title>Magnetic Resonance Imaging ( MRI ) Follow-up Macrophagic Infiltration MS Patients Treated With Tysabri</brief_title>
	<detailed_description />
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Natalizumab</mesh_term>
	<criteria>Patients diagnose MS Treatment Tysabri plan Allergy Tysabri MRI contrast product Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>MRI , PET scan</keyword>
</DOC>